This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Double Trouble for aaiPharma

Shares of aaiPharma (AAII) sank Wednesday, one day after the company said its chief executive had been hospitalized and that its third-quarter results fell below Wall Street estimates.

The stock fell 53 cents, or 14.6%, to $3.09, after falling as low as $3.

Late Tuesday afternoon, the Wilmington, N.C.-based drug company said Dr. Ludo J. Reynders, its president and CEO, has been hospitalized with "suspected pneumonia." While Reynders is incapacitated, the interim president and CEO will be Timothy Wright, who joined the company in April. Wright is the fourth person to hold the title of CEO or interim CEO this year.

Reynders, 50, was named president and CEO on Sept. 28. He replaced Frederick D. Sancilio, 54, the company's founder, who had been chairman, chief executive, president and chief science officer. Sancilio resigned from these positions, but he remains a nonexecutive member of the board of directors. Sancilio had resumed daily management activities in February, replacing Dr. Philip Tabbiner as CEO. Tabbiner joined aaiPharma in 2000 and became CEO in July 2002.

Also, on Tuesday, aaiPharma released third-quarter financial results in which the company reported a loss of $33.8 million, or $1.18 a share, on revenue of $43.2 million. The consensus of analysts polled by Thomson First Call had expected a loss of $9.4 million, or 19 cents a share, on revenue of $51.4 million.

For the same period last year, aaiPharma lost $9.4 million, or 34 cents a share, on revenue of $39.7 million.

The latest aaiPharma results were affected by $13.72 million in restructuring charges, covering severance payments and other employee benefit expenses, making a separation payment to Sancilio and paying lease costs for facilities and aircraft "no longer in use."

Even with the restructuring charge and a $5.3 million charge attributed to impaired assets, analyst David W. Maris still figures aaiPharma lost 55 cents a share. The company's outlook is "uncertain despite progress on some fronts," said Maris, a Banc of America Securities analyst, in a report to clients on Tuesday. "We remain cautious as management continues to provide no guidance or visibility on the company's outlook."
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.65 -0.66%
FB $101.93 0.92%
GOOG $681.92 -0.32%
TSLA $150.01 4.40%
YHOO $26.75 -1.30%


Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs